Adoxima Pty Ltd, is proud to announce the launch of its first product brand, Adjucon. Adjucon is a new company focused exclusively on advanced aluminum manufacturing and the production of vaccine adjuvants, including Aluminum Oxyhydroxide Phosphate, Aluminum Oxyhydroxide Phosphate Sulphate, and Magnetic Adjuvant.
Adoxima has used its cutting-edge DNC technology to fine-tune the physicochemical properties of aluminum vaccine adjuvants, without changing the original product composition. This has resulted in the production of products with superior characteristics, including a higher surface-to-volume ratio, stable colloidal suspension, high antigen absorption, and higher purities.
Adjucon's goal is to bring innovative and effective adjuvants to the world, helping to speed up the development and distribution of vaccines. Adoxima is looking for joint venture opportunities to help bring our to market as quickly as possible.
Adoxima is committed to improving global health and promoting scientific innovation. With the launch of Adjucon, the company is poised to make a significant impact on the vaccine industry and to help bring new, life-saving treatments to patients around the world.
Learn more at www.adjucon.com or email info@adoxima.com for more information
Comentarios